top of page

Managing director and board member with a long successful history in the industry.  The focus is on business development in the field of medical technology. This primarily includes quality management, sales, sales strategy, clinical management, product management, as well as impulses in development.

2018 - 2019   Precision Robotics Ltd., CEO


Precision Robotics Ltd. is a startup from Imperial College in London. The company aims to bring surgical robots to the market that are characterized by their compactness. The company was founded in early 2018 and has a location in Hong Kong in addition to its headquarters in London.

2009 - 2018   Fiagon AG Medical Technologies, CEO


Fiagon AG develops, produces and distributes clinical navigation systems for spine surgery, brain surgery and ENT surgery. Due to the use of a novel disruptive technology, a significant market share has been achieved in more than 42 countries around the world within 10 years. Main competitors are, Medtronic, Stryker, Brainlab and Storz.

2012 - 2013   Federal Ministry of Economics & Technology, Consultant


Appointed to the Advisory Board by Federal Minister Dr. Philipp Rösler, Dr. Timo Krüger attended several Advisory Board meetings with the Minister, State Secretary and companies from other technology sectors as a representative for medical technology. During the German business delegation to Israel led by the Minister, Dr. Timo Krüger was able to conclude a distribution contract worth more than 1 million euros for Fiagon AG as the first highlight of this delegation.

2008 - 2009   University of Applied Sciences Mainz, Professorship


Professorship at University of Applied Sciences Mainz on a substitute basis.

  • Lectures in Special Methods of Equation Calculus, Master

  • Lectures in Geoinformatics and Surveying, Bachelor

  • Lectures in Computer Science, Visual Basic for Applications, Bachelor

2002 - 2009   Charité, Research


Research and development on methods and systems for computer-assisted surgery from the first prototype to permanent clinical use at CHARRITÈ in Berlin. The team included engineers, computer scientists and surgeons.

bottom of page